Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

751
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
751
Metacognition01:26

Metacognition

922
Metacognition is a conscious process where individuals are aware of their cognitive and executive processes, such as planning before solving a problem or self-monitoring during reading. For instance, a writer may need help with composing a piece. The situation involves a writer who is working on a piece of writing, but while doing so, they realize that something is missing. They notice that their characters lack depth or details. This realization occurs because the writer is reflecting on their...
922
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

2.9K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.9K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.7K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.7K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

2.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.3K
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

1.8K
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disinformation elicits learning biases.

eLife·2026
Same author

Could agentic AI topple grant-funding systems?

Nature·2026
Same author

Challenges in replay detection by TDLM in post-encoding resting state.

eLife·2026
Same author

Uncovering the embodied dimension of the wandering mind.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Interoceptive ability is uncorrelated across respiratory and cardiac axes in a large scale psychophysical study.

Communications psychology·2026
Same author

Increased Baseline Pupil Size Linked to Uncertainty Avoidance in Decision Making.

The European journal of neuroscience·2026

Related Experiment Video

Updated: Mar 2, 2026

Disrupting Reconsolidation of Fear Memory in Humans by a Noradrenergic β-Blocker
08:32

Disrupting Reconsolidation of Fear Memory in Humans by a Noradrenergic β-Blocker

Published on: December 18, 2014

23.4K

Noradrenaline blockade specifically enhances metacognitive performance.

Tobias U Hauser1,2, Micah Allen1,3, Nina Purg1

  • 1Wellcome Trust Centre for Neuroimaging, University College London, London, United Kingdom.

Elife
|May 11, 2017
PubMed
Summary

Noradrenergic blockade enhanced metacognitive performance, the ability to assess one

Keywords:
dopaminehumanmetacognitionneurosciencenoradrenaline

More Related Videos

High-definition Transcranial Direct Current Stimulation over Right Dorsolateral Prefrontal Cortex to Enhance Metacognitive Sensitivity
06:11

High-definition Transcranial Direct Current Stimulation over Right Dorsolateral Prefrontal Cortex to Enhance Metacognitive Sensitivity

Published on: September 26, 2025

1.1K
Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance
13:20

Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance

Published on: December 5, 2025

1.1K

Related Experiment Videos

Last Updated: Mar 2, 2026

Disrupting Reconsolidation of Fear Memory in Humans by a Noradrenergic β-Blocker
08:32

Disrupting Reconsolidation of Fear Memory in Humans by a Noradrenergic β-Blocker

Published on: December 18, 2014

23.4K
High-definition Transcranial Direct Current Stimulation over Right Dorsolateral Prefrontal Cortex to Enhance Metacognitive Sensitivity
06:11

High-definition Transcranial Direct Current Stimulation over Right Dorsolateral Prefrontal Cortex to Enhance Metacognitive Sensitivity

Published on: September 26, 2025

1.1K
Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance
13:20

Online Repetitive Transcranial Magnetic Stimulation of Dorsomedial and Dorsolateral Prefrontal Cortex in Cognition Decision Making, and Cognitive Dissonance

Published on: December 5, 2025

1.1K

Area of Science:

  • Neuroscience
  • Cognitive Psychology
  • Psychopharmacology

Background:

  • Metacognitive impairments are prevalent in psychiatric disorders, often linked to neuromodulatory system dysregulation.
  • Previous research demonstrated arousal's influence on metacognition.
  • Understanding the specific roles of noradrenaline and dopamine in metacognition is crucial for potential therapeutic interventions.

Purpose of the Study:

  • To investigate the distinct effects of noradrenaline and dopamine on metacognition and perceptual decision-making.
  • To determine if pharmacological manipulation of these neurotransmitters can modulate metacognitive accuracy.

Main Methods:

  • A double-blind, placebo-controlled study design was employed.
  • Participants performed a global motion discrimination task with adaptive performance staircasing.
  • Signal theoretic analysis quantified metacognitive performance (type-II area under the curve, AUROC2) and perceptual decision-making.
  • Pharmacological agents included propranolol (noradrenergic blockade) and amisulpride (dopamine D2/3 receptor blockade).

Main Results:

  • Noradrenergic blockade with propranolol significantly enhanced metacognitive performance (AUROC2).
  • Noradrenergic blockade did not affect perceptual decision-making performance.
  • Dopamine D2/3 receptor blockade with amisulpride had no significant impact on either metacognition or perceptual decision-making.

Conclusions:

  • This study provides the first evidence for pharmacological enhancement of metacognitive performance.
  • Noradrenergic neurotransmission plays a specific regulatory role in perceptual metacognition.
  • These findings suggest noradrenaline as a potential target for interventions aimed at improving metacognition.